Ikena Oncology, Inc. (IKNA)
NASDAQ: IKNA · Real-Time Price · USD
1.390
-0.060 (-4.14%)
Feb 21, 2025, 4:00 PM EST - Market closed
Ikena Oncology Employees
Ikena Oncology had 43 employees as of December 31, 2023. The number of employees decreased by 37 or -46.25% compared to the previous year.
Employees
43
Change (1Y)
-37
Growth (1Y)
-46.25%
Revenue / Employee
$15,326
Profits / Employee
-$1,386,023
Market Cap
67.08M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 43 | -37 | -46.25% |
Dec 31, 2022 | 80 | 13 | 19.40% |
Dec 31, 2021 | 67 | 34 | 103.03% |
Dec 31, 2020 | 33 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
IKNA News
- 2 months ago - Ikena Oncology and Inmagene Biopharmaceuticals Announce Agreement for Merger and Private Placement - GlobeNewsWire
- 3 months ago - Ikena Oncology Reports Third Quarter 2024 Financial Results - GlobeNewsWire
- 7 months ago - Ikena Oncology Reports Second Quarter 2024 Financial Results - GlobeNewsWire
- 9 months ago - UPDATE – Ikena Oncology Announces Strategic Update - GlobeNewsWire
- 9 months ago - Ikena Oncology Announces Strategic Update - GlobeNewsWire
- 10 months ago - Ikena Oncology Reports First Quarter 2024 Financial Results and Corporate Update - GlobeNewsWire
- 11 months ago - Ikena Oncology to Present at the Stifel 2024 Virtual Targeted Oncology Forum - GlobeNewsWire
- 1 year ago - Ikena Oncology Reports Fourth Quarter and Full Year 2023 Financial Results - GlobeNewsWire